German sarcoma registry for adults with rare tumor types
Part of Cancer clinical trials.
This study is a German “registry,” meaning it collects information about people with specific bone or soft tissue tumors (including some borderline or hard-to-classify cases). It helps doctors and researchers learn more about these rare conditions to improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- Your diagnosis must be confirmed by pathology (lab/tissue results) as a sarcoma or a related tumor type.
- Your tumor type can include bone or soft-tissue sarcomas, or borderline/unclear cases (for example, certain giant cell, desmoid, or atypical fat tumor types).
- Your tumor can also be a “sarcomatoid carcinoma/carcinosarcoma,” which has features of both carcinoma (from tissue lining) and sarcoma (connective tissue).
- You must be able to sign an informed consent form (or equivalent permission).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a health registry that collects information about people with soft-tissue or bone sarcoma. It helps researchers understand how the disease behaves and what outcomes different treatments lead to.
This study is for people who have been diagnosed with bone or soft tissue sarcoma confirmed by a tissue test. It may help researchers understand sarcoma better, but you must be able to understand and consent to take part.
This trial builds a national database of people diagnosed with sarcoma in French cancer centers. It may help researchers better understand sarcoma types and care patterns, which can improve future treatment decisions.
This study collects information from European hospitals on people with epithelioid hemangioendothelioma (EHE), a rare tumor that grows in blood vessels. Joining this registry helps doctors learn more about the disease and improve care for others.
This study collects information and blood samples from adults with sarcoma who had surgery and possibly radiation. The goal is to build a large dataset that helps researchers understand sarcoma better and improve future care.
This study collects blood and tissue samples from people with high-risk soft tissue sarcoma before their surgery. The goal is to learn how the immune system responds to pre-surgery treatments like radiation and hyperthermia (heat therapy).
Hear when a new Sarcoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.